{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Okuno K"],"funding":["Foundation for the National Institutes of Health"],"pubmed_abstract":["<h4>Background</h4>Naturally occurring dietary botanicals offer time-tested safety and anti-cancer efficacy, and a combination of certain compounds has shown to overcome the elusive chemotherapeutic resistance, which is of great significance for improving the mortality of patients with colorectal cancer (CRC). Accordingly, herein, we hypothesized that berberine (BBR) and oligomeric proanthocyanidins (OPCs) might regulate synergistically multiple oncogenic pathways to exert a superior anti-cancer activity in CRC.<h4>Methods</h4>We performed a series of cell culture studies, followed by their interrogation in patient-derived organoids to evaluate the synergistic effect of BBR and OPCs against CRC. In addition, by performing whole genome transcriptomic profiling we identified the key targeted"],"journal":["Frontiers in oncology"],"pagination":["855860"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9114748"],"repository":["biostudies-literature"],"pubmed_title":["Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer."],"pmcid":["PMC9114748"],"pubmed_authors":["Okuno K","Goel A","Garg R","Tokunaga M","Kinugasa Y","Yuan YC"],"additional_accession":[]},"is_claimable":false,"name":"Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.","description":"<h4>Background</h4>Naturally occurring dietary botanicals offer time-tested safety and anti-cancer efficacy, and a combination of certain compounds has shown to overcome the elusive chemotherapeutic resistance, which is of great significance for improving the mortality of patients with colorectal cancer (CRC). Accordingly, herein, we hypothesized that berberine (BBR) and oligomeric proanthocyanidins (OPCs) might regulate synergistically multiple oncogenic pathways to exert a superior anti-cancer activity in CRC.<h4>Methods</h4>We performed a series of cell culture studies, followed by their interrogation in patient-derived organoids to evaluate the synergistic effect of BBR and OPCs against CRC. In addition, by performing whole genome transcriptomic profiling we identified the key targeted","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-25T18:02:51.27Z","creation":"2024-11-06T02:22:59.678Z"},"accession":"S-EPMC9114748","cross_references":{"pubmed":["35600365"],"doi":["10.3389/fonc.2022.855860"]}}